138 related articles for article (PubMed ID: 31317548)
1. Establishment of BALB/C mouse models of influenza A H1N1 aerosol inhalation.
Hao XY; Li FD; Lv Q; Xu YF; Han YL; Gao H
J Med Virol; 2019 Nov; 91(11):1918-1929. PubMed ID: 31317548
[TBL] [Abstract][Full Text] [Related]
2. Experimental infection of Cynomolgus Macaques with highly pathogenic H5N1 influenza virus through the aerosol route.
Watanabe T; Iwatsuki-Horimoto K; Kiso M; Nakajima N; Takahashi K; Jose da Silva Lopes T; Ito M; Fukuyama S; Hasegawa H; Kawaoka Y
Sci Rep; 2018 Mar; 8(1):4801. PubMed ID: 29556081
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intranasal and aerosol infection of mice in assessment of immunity to influenza virus infection.
Johansson BE; Kilbourne ED
J Virol Methods; 1991 Nov; 35(1):109-14. PubMed ID: 1666111
[TBL] [Abstract][Full Text] [Related]
4. The characteristics of hDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose-only exposure device.
Hao XY; Lv Q; Li FD; Xu YF; Gao H
Animal Model Exp Med; 2019 Dec; 2(4):269-281. PubMed ID: 31942559
[TBL] [Abstract][Full Text] [Related]
5. Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection.
Marriott AC; Dennis M; Kane JA; Gooch KE; Hatch G; Sharpe S; Prevosto C; Leeming G; Zekeng EG; Staples KJ; Hall G; Ryan KA; Bate S; Moyo N; Whittaker CJ; Hallis B; Silman NJ; Lalvani A; Wilkinson TM; Hiscox JA; Stewart JP; Carroll MW
PLoS One; 2016; 11(6):e0157887. PubMed ID: 27311020
[TBL] [Abstract][Full Text] [Related]
6. Proportional mouse model for aerosol infection by influenza.
McDonald RS; Sambol AR; Heimbuch BK; Brown TL; Hinrichs SH; Wander JD
J Appl Microbiol; 2012 Oct; 113(4):767-78. PubMed ID: 22809111
[TBL] [Abstract][Full Text] [Related]
7. Aerosol inoculation with a sub-lethal influenza virus leads to exacerbated morbidity and pulmonary disease pathogenesis.
Smith JH; Nagy T; Barber J; Brooks P; Tompkins SM; Tripp RA
Viral Immunol; 2011 Apr; 24(2):131-42. PubMed ID: 21449723
[TBL] [Abstract][Full Text] [Related]
8. Replication of an H9N2 Avian Influenza Virus and Cytokine Gene Expression in Chickens Exposed by Aerosol or Intranasal Routes.
Guan J; Fu Q; Sharif S
Avian Dis; 2015 Jun; 59(2):263-8. PubMed ID: 26473677
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized pH1N1 influenza infection induces less systemic and local immune activation in the lung than combined intrabronchial, nasal and oral exposure in cynomolgus macaques.
Mooij P; Mortier D; Stammes M; Fagrouch Z; Verschoor EJ; Bogers WMJM; Koopman G
J Gen Virol; 2020 Dec; 101(12):1229-1241. PubMed ID: 32975505
[TBL] [Abstract][Full Text] [Related]
10. The 2009 pandemic H1N1 influenza virus is more pathogenic in pregnant mice than seasonal H1N1 influenza virus.
Kim HM; Kang YM; Song BM; Kim HS; Seo SH
Viral Immunol; 2012 Oct; 25(5):402-10. PubMed ID: 22985287
[TBL] [Abstract][Full Text] [Related]
11. Comparison of traditional intranasal and aerosol inhalation inoculation of mice with influenza A viruses.
Belser JA; Gustin KM; Katz JM; Maines TR; Tumpey TM
Virology; 2015 Jul; 481():107-12. PubMed ID: 25771498
[TBL] [Abstract][Full Text] [Related]
12. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
[TBL] [Abstract][Full Text] [Related]
13. A mouse model of aerosol-transmitted orthopoxviral disease: morphology of experimental aerosol-transmitted orthopoxviral disease in a cowpox virus-BALB/c mouse system.
Martinez MJ; Bray MP; Huggins JW
Arch Pathol Lab Med; 2000 Mar; 124(3):362-77. PubMed ID: 10705388
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
[TBL] [Abstract][Full Text] [Related]
15. The protective effects of intranasal administration of IL-12 given before influenza virus infection and the negative effects of IL-12 treatment given after viral infection.
Ishikawa H; Ino S; Sasaki H; Fukui T; Kohda C; Tanaka K
J Med Virol; 2016 Sep; 88(9):1487-96. PubMed ID: 26864280
[TBL] [Abstract][Full Text] [Related]
16. Single-walled carbon nanotubes modulate pulmonary immune responses and increase pandemic influenza a virus titers in mice.
Chen H; Zheng X; Nicholas J; Humes ST; Loeb JC; Robinson SE; Bisesi JH; Das D; Saleh NB; Castleman WL; Lednicky JA; Sabo-Attwood T
Virol J; 2017 Dec; 14(1):242. PubMed ID: 29273069
[TBL] [Abstract][Full Text] [Related]
17. Lianhuaqingwen capsule inhibits non-lethal doses of influenza virus-induced secondary Staphylococcus aureus infection in mice.
Song J; Zhao J; Cai X; Qin S; Chen Z; Huang X; Li R; Wang Y; Wang X
J Ethnopharmacol; 2022 Nov; 298():115653. PubMed ID: 35995276
[TBL] [Abstract][Full Text] [Related]
18. Replication and pathogenesis of the pandemic (H1N1) 2009 influenza virus in mammalian models.
Kwon D; Shin K; Kim S; Ha Y; Choi JH; Yang JS; Lee JY; Chae C; Oh HB; Kang C
J Microbiol; 2010 Oct; 48(5):657-62. PubMed ID: 21046344
[TBL] [Abstract][Full Text] [Related]
19. Postinfection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected mice.
Aeffner F; Bratasz A; Flaño E; Powell KA; Davis IC
Am J Respir Cell Mol Biol; 2012 Oct; 47(4):543-51. PubMed ID: 22679275
[TBL] [Abstract][Full Text] [Related]
20. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.
Tumpey TM; García-Sastre A; Taubenberger JK; Palese P; Swayne DE; Pantin-Jackwood MJ; Schultz-Cherry S; Solórzano A; Van Rooijen N; Katz JM; Basler CF
J Virol; 2005 Dec; 79(23):14933-44. PubMed ID: 16282492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
